UPDATE 2-FDA approves Celgene's bone marrow cancer treatment
August 16, 2019 at 13:37 PM EDT
The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease.